|1.||Hsieh, Chung-Cheng: 3 articles (05/2015 - 09/2011)|
|2.||Cnattingius, Sven: 3 articles (05/2015 - 09/2011)|
|3.||Lambe, Mats: 3 articles (05/2015 - 09/2011)|
|4.||Johansson, Anna L V: 3 articles (05/2015 - 09/2011)|
|5.||Andersson, Therese M-L: 3 articles (05/2015 - 09/2011)|
|6.||Borges, Virginia F: 3 articles (06/2013 - 06/2009)|
|7.||Theriault, Richard L: 3 articles (01/2010 - 01/2002)|
|8.||Székely, Borbála: 2 articles (07/2014 - 08/2010)|
|9.||Kulka, Janina: 2 articles (07/2014 - 08/2010)|
|10.||Dank, Magdolna: 2 articles (07/2014 - 08/2010)|
07/01/2008 - "Although PABC and BC tumor size, grade and type, and lymphovascular and lymphnode invasion were similar, the BC cases showed better overall--(p=0.0001) and disease-free (p-0.015) survival. "
04/01/2014 - "A single-institution study of 117 pregnancy-associated breast cancers (PABC): Presentation, imaging, clinicopathological data and outcome."
06/28/2012 - "In general, the PEG-VC-PABC-PTX conjugate designed in this study demonstrated significant advantages in terms of high water solubility, no toxic surfactant or organic solvent, tumor environment-sensitivity and high therapeutic index."
09/01/2011 - "This study investigated the mortality in women with PABC in relation to when the tumor was detected (during pregnancy, different postpartum periods) and by time since diagnosis, compared with women with non-PABC. "
09/01/2015 - "Administration of the anti-endosialin-MC-VC-PABC-MMAE conjugate resulted in a marked prolonged tumor response of both xenograts. "
|3.||Breast Neoplasms (Breast Cancer)
10/01/2014 - "The primary objective of this study was to evaluate the clinicopathological characteristics of patients with pregnancy-associated breast cancer (PABC), with a special focus on diagnostic delays and the identifiable causes of diagnostic delays. "
04/01/2014 - "This retrospective single-institution study was designed to describe the main clinical, radiological and histological features, as well as the outcome of pregnancy-associated breast cancer (PABC), with a special emphasis on imaging and diagnostic difficulties. "
03/04/2014 - "A retrospective, analytical, observational study comparing 56 cases of breast cancer and pregnancy (PABC) diagnosed 1976-2008 with 73 patients with breast cancer not associated with pregnancy (non-PABC) was performed. "
02/01/2014 - "We performed a mono-institutional study for evaluating the biological data, such as p53, Ki67 and BRCA mutations, as well as clinical characteristics of pregnancy associated breast cancer (PABC), its therapeutic management and the prognosis in a small cohort of patients. "
01/01/2014 - "This study investigated the clinicopathologic characteristics and survival of women diagnosed with pregnancy-associated breast cancer (PABC) in Taiwan. "
|4.||Neoplasm Metastasis (Metastasis)
03/15/2009 - "The purpose of the current study was to compare locoregional recurrence (LRR), distant metastases (DM), and overall survival (OS) in young patients with PABC and non-PABC. "
06/01/2013 - "This suggests that the heightened aggressiveness of PABC may involve a predisposition to metastasis through extracellular matrix degradation, plus angiogenesis independence. "
06/01/2009 - "If we determine the mechanisms by which involution promotes metastasis of PABC, the post-partum period can be a window of opportunity for intervention strategies."
08/01/2015 - "Although PABC is usually discovered in an advanced stage, breast cancer metastasis on the placenta is a rare event. "
01/01/2011 - "Our study supports the involvement of miR-21 in breast cancer progression and metastasis formation in PABC implying a role of this miRNA as a marker for poor prognosis in PABC patients."
07/01/2008 - "Forty patients with PABC were compared with 61 non-pregnant, age-matched patients with infiltrative breast carcinomas (BC) diagnosed and followed since 1982. "
06/01/2012 - "Ac-Phe-Lys-PABC-ADM could be an effective molecular targeting drug to treat gastric cancer peritoneal carcinomatosis with enhanced efficacy and reduced toxicity."
06/01/2012 - "The authors examined the antitumor effect and toxicities of Ac-Phe-Lys-PABC-ADM against gastric cancer peritoneal carcinomatosis. "
06/01/2012 - "The in vivo study investigated the efficacy and toxicity of Ac-Phe-Lys-PABC-ADM on a nude mice model of peritoneal carcinomatosis, with doxorubicin as positive control. "
06/01/2012 - "In the in vivo study of control, doxorubicin, and Ac-Phe-Lys-PABC-ADM groups, the median experimental peritoneal carcinomatosis indexes were 6, 1.5, and 1, respectively (P = .004); the body weights were 24.32 ± 1.40 g, 18.40 ± 2.97 g, and 23.61 ± 0.80 g, respectively (P = .000). "
|6.||Polyethylene Glycols (Polyethylene Glycol)
|7.||Excipients (Suspending Agents)
|1.||Counterpulsation (External Counterpulsation)
|2.||Left Heart Bypass
|5.||Segmental Mastectomy (Lumpectomy)